Iovance Biotherapeutics, Inc.
2020 Q3 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/28/2026 | 123 | 0.0% | 45,047 | 12/31/2025 |
| 2025 Q3 | 10/30/2025 | 141 | 0.0% | 64,786 | 9/30/2025 |
| 2025 Q2 | 8/1/2025 | 121 | 0.0% | 70,378 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 191 | 0.0% | 57,415 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 466 | 0.0% | 63,025 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 461 | 0.0% | 49,130 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 344 | 0.0% | 42,928 | 6/30/2024 |
| 2024 Q1 | 5/6/2024 | 633 | 0.0% | 42,720 | 3/31/2024 |
| 2023 Q4 | 2/7/2024 | 419 | 0.0% | 51,598 | 12/31/2023 |
| 2023 Q3 | 10/31/2023 | 288 | 0.0% | 63,289 | 9/30/2023 |
| 2023 Q2 | 7/19/2023 | 361 | 0.0% | 51,294 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 223 | 0.0% | 36,468 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 228 | 0.0% | 35,722 | 12/31/2022 |
| 2022 Q3 | 11/3/2022 | 369 | 0.0% | 38,562 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 221 | 0.0% | 20,031 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 430 | 0.0% | 25,809 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 451 | 0.0% | 23,627 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 467 | 0.0% | 18,946 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 370 | 0.0% | 14,211 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 382 | 0.0% | 12,056 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 455 | 0.0% | 9,798 | 12/31/2020 |
| 2020 Q3 | 11/2/2020 | 201 | 0.0% | 6,110 | 9/30/2020 |